Additionally, N1DARP competitively inhibits the binding between N1ICD and USP10, promoting K11 and K48 ubiquitin-mediated degradation of N1ICD [122], which consequently suppresses the Notch signalling pathway and reduces pancreatic cancer stem cell properties. Here, USP10 is linked to pancreatic neoplasm.